Hypera S.A. (HYPMY)
OTCMKTS
· Delayed Price · Currency is USD
2.920
-0.070 (-2.34%)
Dec 24, 2024, 4:00 PM EST
Hypera Revenue
Hypera had revenue of 1.92B BRL in the quarter ending September 30, 2024, a decrease of -10.41%. This brings the company's revenue in the last twelve months to 7.78B, down -5.02% year-over-year. In the year 2023, Hypera had annual revenue of 7.91B with 4.88% growth.
Revenue (ttm)
7.78B BRL
Revenue Growth
-5.02%
P/S Ratio
n/a
Revenue / Employee
755.11K BRL
Employees
10,301
Market Cap
1.91B USD
Revenue Chart
* This company reports financials in BRL.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7.91B | 368.30M | 4.88% |
| Dec 31, 2022 | 7.55B | 1.61B | 27.10% |
| Dec 31, 2021 | 5.94B | 1.85B | 45.21% |
| Dec 31, 2020 | 4.09B | 794.12M | 24.10% |
| Dec 31, 2019 | 3.29B | -429.56M | -11.53% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.66B |
| Ryman Healthcare Limited | 458.44M |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |
Hypera News
- 4 weeks ago - Hypera: Short-Term Pain For Long-Term Gain - Seeking Alpha
- 4 years ago - Hypera S.A.: Adding The Brazilian Pharma To Your Portfolio - Seeking Alpha
- 4 years ago - A Brazilian-Focused Dividend Portfolio - Seeking Alpha